Managed a team of eight in the Office of Clearing and Settlement conducting examinations of clearing agencies and swap data repositories, including systemically important clearing agencies. The team also conducted an evaluation of the risk and market impact of short-dated options and zero day to expiration options.

Primary legal counsel to the Management Team concerning clearing house matters. Appointed CCO in 2011. Led team of five (including three attorneys) to develop and conduct the compliance program, Annual Compliance Report submission. Managed all aspects of Title VIII regulatory compliance exams conducted by Commodity Futures Trading Commission, Federal Reserve and Securities Exchange Commission for risk management and system safeguards exams. • Responsible for all required recurring ad hoc reporting to regulatory authorities in the United States and 10 international jurisdictions. • Led the project to achieve regulatory status for CME Clearing Europe in the United States and United Kingdom. • Lead contact for regulatory authority inquiries. • Member of the Clearing House Management Team. • Liasion to the Clearing House Oversight Committee and Clearing House Risk Committee.• Managed transactional matters for the Clearing House, including technology transactions and master service consulting agreements for annual validations of six margin models. • Managed multi- million dollar budget for third party consulting services.• Developed clearing rules to clear and settle OTC products. • Obtained required regulatory approvals for CME Clearing Europe. • Responsible for clearing agency application of CME Securities Clearing Corporation.